Engineering Nanoplatform for Combined Cancer Therapeutics via Complementary Autophagy Inhibition

Despite advances in the development of tumor treatments, mortality from cancer continues to increase. Nanotechnology is expected to provide an innovative anti-cancer therapy, to combat challenges such as multidrug resistance and tumor recurrence. Nevertheless, tumors can greatly rely on autophagy as...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xuan, Li, Yunhao, Lu, Jianqing, Deng, Xiongwei, Wu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776236/
https://www.ncbi.nlm.nih.gov/pubmed/35054843
http://dx.doi.org/10.3390/ijms23020657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776236/
https://www.ncbi.nlm.nih.gov/pubmed/35054843
http://dx.doi.org/10.3390/ijms23020657

Ejemplares similares